Mohammad Haider Khan, & Muhammad Syed Ali Hamza. (2026). Resmetirom in fatty liver disease: A promising step ahead in metabolic dysfunction-associated steatotic liver disease treatment. Journal of the Pakistan Medical Association, 76(06), 1002–1002. https://doi.org/10.47391/JPMA.32704